| Updates to existing prior authorization programs | |||
| Drug | Plan | Eff. date | Policy & additional information |
| Non-Formulary Exceptions | Harvard Pilgrim Commercial, Tufts Health Plan Commercial, Tufts Health Direct | 5/1/2025 | Non-Formulary Exceptions
For formularies subject to non-formulary review, added coverage criteria for Zepbound’s supplemental indication for moderate to severe obstructive sleep apnea in obesity. |